A growing number of genetic evidence indicated that the single-nucleotide polymorphisms (SNPs) in the ERCC4 and ERCC5 genes may vary susceptibility to malignant tumor; previous studies have demonstrated that ERCC4 rs1800067 was associated with the risks of lung cancer, breast cancer, and glioma (13–15). Here, ERCC4 is linked to central nervous system cancer.